Clinical Trials Browser

Phase 2 × Digestive System Neoplasms × pyrotinib × Clear all

NCT04960943 2021-07-14

Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms